Skip to content

Home
Columns
- Overcoming Adversity
News Categories
About Lymphoma
Lymphoma Drugs
- Approved Treatments
  - Rituxan (Rituximab)
  - Aliqopa (Copanlisib)
- Experimental Treatments

Search for:

Patient Stories: Cancer-Related Fatigue

April 22, 2016

In Social Clips.

In this Lymphoma Association video, Keren talks about her experience with cancer-related fatigue.

Learn more about lymphoma here: http://bit.ly/1UwWKe6

Print Friendly, PDF & Email

Print This Page

Tagged fatigue, Lymphoma Association.

admin

Post navigation

Previous: Kiernan’s Story: “We Can’t Give Up”

Next:Living with Lymphoma: Tony Wootton

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Search for:

Recent Posts

AFM11 Clinical Program for Lymphoma and Leukemia on Hold Over Safety Concerns

October 17, 2018
Publication of Phase 3 Trial Results Supports FDA Approval of Copiktra, Verastem Announces

October 16, 2018
FDA Committee Recommends Truxima’s Approval for 3 Non-Hodgkin’s Lymphoma Indications

October 15, 2018
Axicabtagene Ciloleucel Gets Japan’s Orphan Drug Designation to Treat Some Non-Hodgkin’s Lymphomas

October 12, 2018
Beigene’s Lymphoma Treatment Zanubrutinib Shows High Response Rates in Chinese Phase 1 Trial

October 11, 2018
9 in 10 Heavily Treated CTCL Patients See Benefits with IPH4102, Phase 1 Trial Shows

October 10, 2018
LLS Seeks Corporate Support for Annual ‘Light The Night’ Campaign

October 9, 2018
Portola’s Cerdulatinib Wins Orphan Drug Designation for Peripheral T-cell Lymphoma

October 8, 2018
Embracing the Insecurity

October 8, 2018
We Need to Talk About Survival Statistics

October 5, 2018
Adcetris Added to Front-line Chemo Significantly Improves Survival in PTCL Patients, Phase 3 Trial Shows

October 4, 2018
Adcetris-Gemcitabine Combo Eliminates Cancer in Two-thirds of Hodgkin’s Lymphoma Patients in Phase 1/2 Trial

October 3, 2018

Featured Posts

Hope Matters As I Celebrate My 10-Year ‘Diagnosiversary’

August 10, 2018

Nearly Half of NHL Patients in Phase 1 Trial Respond to ALT-803, Rituxan Combo, Results Show

April 26, 2018

Takeda, Nectar Plan to Test New IO Combination in non-Hodgkin Lymphoma Patients

May 4, 2018

Visit Lymphoma News Today's profile on Pinterest.

Lymphoma News Today

BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: [email protected]
Phone: 1-800-936-1363

About Us
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2018 Copyright 2015 © All rights reserved

Pin It on Pinterest

Share This

Facebook
Twitter
Google+
Pinterest
LinkedIn

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. Ok Read more